首页 >
法规速递
-
Document: Minutes - PDCO minutes of the 11-14 November 2025 meeting-2026/1/15
2026-01-16查看详情 > -
国家药监局药审中心关于发布《新药全球同步研发中基于多区域临床试验数据进行获益-风险评估的指导原则（试行）》的通告（2026年第18号）-2026/2/24
2026-02-27查看详情 > -
Document: List of medicinal products under additional monitoring-2026/3/25
2026-03-26查看详情 > -
Page: Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions-2026/4/29
2026-04-30查看详情 > -
Page: Substance and product data management services-2026/6/12
2026-06-15查看详情 > -
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments (Final)-2022/10/5
2022-11-15查看详情 > -
Draft Guidance: Over-the-Counter Monograph Order Requests: Format and Content-2023/4/12
2023-04-13查看详情 > -
药品经营和使用质量监督管理办法-2023/10/13
2023-10-13查看详情 > -
Document: Opinion of the CVMP on the establishment of maximum residue limits: Rafoxanide-2025/1/7
2025-01-08查看详情 > -
国家药监局关于注销肺结节CT图像辅助检测软件等3个医疗器械注册证书的公告（2025年第5号）-2025/2/17
2025-02-18查看详情 >
